… Withholding stereotactic radiotherapy in elderly patients with stage i non-small cell lung
cancer and co-existing COPD is not justified: Outcomes of a markov model analysis …

… Given the progressive increase of patients in our center rejected for surgery due to … a cohort
of stage I-IIA non-small cell lung cancer (NSCLC) or lung metastases in COPD patients with …

… presence of chronic obstructive pulmonary disease (COPD) and pulmonary emphysema (PE…
to evaluate the therapeutic efficacy of SBRT in T1-2N0M0 NSCLC patients with ILD who are …

… the feasibility for lung resection, and radiation therapy including stereotactic body radiotherapy
(… As early curative surgical treatment affects the subsequent treatment, we separated …

… enrolled in this study had underlying lung diseases, such as COPD or IPF with impaired
pulmonary function. Grade 3 radiation pneumonitis requiring hospitalization occurred in two …

… treatment for stage I non-small cell lung cancer (NSCLC) in medically operable patients. …
the optimal treatment with curative intent, less recurrences and improved survival, taking …

… of stereotactic ablative radiotherapy (SABR) to patients with early-stage non–small cell lung
cancer and interstitial lung … In any patient with ILD and early-stage NSCLC, alternate curative-…

… candidates with non–small cell lung cancer (NSCLC) were treated with … stereotactic
radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer…

… and consequently they often do not receive any curative therapy. … fit patients with clinical
T1aN0 non-small-cell lung cancer. These … [18] The risk of lung cancer in patients with COPD …

… for patients with stage IV lung cancer, into the curative therapy … with high rates of emphysema
and heart disease leading to … therapy is definitive stereotactic body radiation therapy (…